Hemolytic Anemia Notes
Hemolytic Anemia
Objectives
Define hemolysis and explain the term 'compensated hemolysis.'
List hematological and biochemical indicators of red cell hemolysis.
Classify the principal causes of red blood cell hemolysis (e.g., extracorpuscular and intracorpuscular) and cite examples from each category.
List and briefly discuss laboratory tests used to differentiate between intravascular and extravascular hemolysis.
Explain the principles of the osmotic fragility test.
Compare the inheritance pattern of hereditary spherocytosis with that of glucose 6 phosphate dehydrogenase deficiency.
Explain the difference between alloimmune and autoimmune hemolysis.
The Normal Removal Of The RBCs
RBC life span is approximately 120 days.
RBC destruction occurs after this mean life span.
Removal happens in the extravascular space by the reticuloendothelial system (phagocytic system) in the bone marrow, spleen, and liver.
Hemolysis
Hemolysis is the accelerated destruction of red blood cells (RBCs), leading to decreased RBC survival.
The bone marrow's response to hemolysis is increased erythropoiesis, reflected by reticulocytosis.
Compensated Hemolysis: If the rate of hemolysis is modest and the bone marrow can completely compensate for the decreased RBC life span, the hemoglobin concentration may be normal.
Incompletely Compensated Hemolysis: If the bone marrow cannot completely compensate for hemolysis, anemia occurs.
A normal hemoglobin value does not necessarily denote the absence of hemolysis.
Hemolysis Classification
Multiple ways to classify hemolysis:
Inheritance: Inherited vs. Acquired
Site of RBC destruction:
Intravascular: inside blood vessels (e.g., Paroxysmal nocturnal hemoglobinuria (PNH))
Extravascular: macrophages in the reticuloendothelial system (liver and spleen); more common (e.g., hereditary spherocytosis)
Origin of RBC damage:
Intrinsic: to RBC, usually inherited (but not always, e.g., PNH)
Extrinsic: to RBC, usually acquired (but not always, e.g., congenital Thrombotic Thrombocytopenic Purpura (TTP))
Clinical Manifestations
History/Physical:
Fatigue
Pallor
Jaundice
Splenomegaly (in some cases)
Free hemoglobin scavenges nitric oxide, so chronically this can result in:
Esophageal spasm
Non-healing skin ulcers
Pulmonary hypertension
Chronic intravascular hemolysis:
Hemosiderinuria
Chronic extravascular hemolysis:
Pigmented gallstones
Haptoglobin
Haptoglobins are proteins in normal plasma which bind hemoglobin if either intravascular or significant extravascular hemolysis is present.
The hemoglobin–haptoglobin complex is removed by the RE system, leading to low haptoglobin levels in hemolysis.
Hemolysis Biomarkers
Haptoglobin binds with Hb
(Haptoglobin + Hb) Complex is removed by the mononuclear phagocytic system
This leads to low haptoglobin levels
Indicators of Red Cell Hemolysis
Features of increased red cell breakdown:
(a) Serum bilirubin raised, unconjugated and bound to albumin
(b) Urine urobilinogen increased
(c) Serum haptoglobins absent because the haptoglobins become saturated with hemoglobin, and the complex is removed by RE cells.
Features of increased red cell production:
(a) Reticulocytosis
(b) Bone marrow erythroid hyperplasia – the normal marrow myeloid : erythroid ratio of 2:1 to 12:1 is reduced to 1:1 or reversed.
Damaged red cells, visualized by:
(a) Routine blood film morphology (e.g., microspherocytes, elliptocytes, fragments)
(b) Flow cytometry after eosin-maleimide (EMA) staining
(c) Specific enzyme, protein, or DNA tests.
Intravascular vs. Extravascular Hemolysis
Intravascular hemolysis: erythrocytes are destroyed in the blood vessel itself.
Extravascular hemolysis: occurs in the hepatic and splenic macrophages within the reticuloendothelial system.
Intravascular Hemolysis Details
Red cell destruction occurs primarily in the vascular space.
Damage to the RBC membrane is significant.
Can be detected by blood test → Hemoglobinemia.
Free hemoglobin in the urine. Hemoglobinuria → Acute renal failure.
Hemosiderin → Iron deficiency anemia. The byproduct of hemolysis → free hemoglobin.
Causes of Intravascular Hemolysis
Micro-angiopathic hemolytic anemia (MAHA): hemolytic anemia, thrombocytopenia, and microvascular thrombosis.
Thrombotic thrombocytopenic purpura (TTP).
Shear stress: aortic stenosis, defective prosthetic valve.
Acute hemolytic transfusion reactions (e.g., ABO incompatibility).
Infections: clostridia sepsis, severe malaria.
Paroxysmal cold hemoglobinuria & cold agglutinin disease (cold AIHA).
Paroxysmal nocturnal hemoglobinuria (PNH).
Extravascular Hemolysis Details
Red cell destruction primarily in the Reticuloendothelial system.
Examples:
Warm Autoimmune hemolysis
Delayed hemolytic transfusion reactions
Hemoglobinopathies (sickle cell and thalassemia)
Hereditary spherocytosis
AIHA (Autoimmune Hemolytic Anemia)
Shortened survival of RBCs due to auto-antibodies.
Warm AIHA:
Antibodies bind to RBCs optimally at body temperature (37^{\circ}C).
Almost always due to IgG.
80-90% of AIHA.
Cold AIHA:
Antibodies bind to RBCs optimally at temperature < 37^{\circ}C (optimum temperature of 3 to 4^{\circ}C).
Almost always due IgM.
Cold reacting IgG
10-20% of AIHA.
Alloimmune Hemolytic Anemia
Antibodies are directed against transfused RBCs/foreign RBC antigen:
Incompatible blood transfusion:
Acute hemolytic transfusion reaction.
Delayed hemolytic transfusion reaction.
Pregnancy.
Laboratory Testing for Hemolytic Anemia
Test | Type | Comment |
|---|---|---|
Direct antiglobulin (DAT) | Autoimmune | Initial test for any type of hemolytic anemia |
Enhanced DAT | Acquired | DAT negative but AIHA still suspected |
Cold agglutinin titer | Cold agglutinin disease | |
Donath-Landsteiner | Paroxysmal cold hemoglobinuria | |
ADAMTS13 level | Thrombotic thrombocytopenic purpura | |
Serologic complement | Complement-mediated thrombotic Microangiopathy | |
Genetic complement | Complement-mediated thrombotic Microangiopathy | |
Flow cytometry | Paroxysmal nocturnal hemoglobinuria | |
Eosin-5-maleimide (EMA) binding | Hereditary | Hereditary spherocytosis, elliptocytosis (some) |
Osmotic fragility | Hereditary | Hereditary spherocytosis |
RBC enzyme activity | RBC enzymopathy | |
Next generation sequencing | All types | For select patients |
Labs to Order - Intravascular vs Extravascular Hemolysis
Test | Intravascular Hemolysis | Extravascular Hemolysis | Note |
|---|---|---|---|
Reticulocytes | Increase | Increase | Both |
Unconjugated bilirubin | Increase | Unchanged/mild decrease | Both |
LDH | Increase | Unchanged/mild decrease | Both |
Peripheral smear | Schistocytes | Spherocytes | Schistocytes (fragments) |
Haptoglobin | Decrease | Unchanged/mild decrease | |
Urine hemosiderin | Positive after ~1 week | Negative | |
Urine hemoglobin | Positive | Negative | |
Carboxyhemoglobin | Increase | Negative |
Intracorpuscular vs. Extracorpuscular Hemolysis
Intracorpuscular Causes:
Hereditary:
Enzyme defects:
G6PD deficiency
Pyruvate kinase deficiency
Defects in the RBC membrane:
Hereditary spherocytosis
Hereditary elliptocytosis
Hemoglobinopathies:
Thalassemia syndrome
Hb S, Hb C
Acquired:
Paroxysmal nocturnal hemoglobinuria
Infections from Clostridia and P.falciparum
Extracorpuscular Causes:
Immune hemolytic anemia
Chemicals and toxins
Physical agents
Infections
Hypersplenism
Microangiopathic hemolytic anemia
Macroangiopathic hemolytic anemia
Intracorpuscular - Intrinsic Defect
Membrane defect: Hereditary spherocytosis.
Enzyme defect: G6PD deficiency.
HB defect: Hemoglobinopathies.
Intracorpuscular vs. Extracorpuscular - Key Points
Intrinsic hemolysis most of the time is due to congenital / inherited causes.
Inherited TTP→ extrinsic hemolysis.
Extrinsic hemolysis most of time is due to acquired causes.
PNH (acquired)→ intrinsic hemolysis
RBC Membrane Disorders
Include:
Hereditary spherocytosis
Hereditary elliptocytosis
Hereditary pyropoikilocytosis
Characterized by:
Deficiency or dysfunction of one or more membrane proteins
Shortened RBC survival by hemolysis
Hereditary Spherocytosis
Epidemiology:
Common in Northern Europeans
Inheritance pattern:
75% autosomal dominant
25% sporadic
Pathophysiology:
Aberrant interaction between the skeleton and overlying lipid bilayer
“Vertical interactions”
Spherocytes
Don’t deform easily making it difficult to travel through the splenic vascular walls à further membrane loss
sphErocytes = Extravascular hemolysis
Causes: defect in RBC membrane:
Ankyrin
spectrin
Band 3 mutation
Protein 4.2
Osmotic Fragility Test
Osmotic fragility testing: Increasing hypotonic saline solutions
Increased RBC lysis compared with normal RBCs
Sensitivity enhanced by 24 h incubation at 37^{\circ}C
Not specific for HS (spherocytes of any cause will be positive)
Osmotic Fragility Test for HS
Osmotic fragility is a test to measure red cell hemolysis
Cell resistance to hemolysis when exposed to a series of increasingly dilute saline solution
The sooner hemolysis occurs, the greater the osmotic fragility of the cells.
G6PD Deficiency
Most frequently encountered abnormality of RBC metabolism
Affects >200 million people worldwide
Survival advantage with P. Falciparum
Pathophysiology:
Hemolysis = due to failure to generate adequate NADPH
Leads to decreased levels of reduced glutathione
RBCs susceptible to oxidation of Hb by oxidant radicals
Denatured Hb aggregates form intraerythrocytic Heinz bodies
Heinz bodies bind to RBC cytoskeleton leads to reduced cellular deformity
Cells with Heinz bodies are trapped in the spleen, cell membrane becomes pitted and is lost, hemolysis
Inheritance:
Gene for G6PD is on X-chromosome
Hemolysis Triggers in G6PD Deficiency
Infections and other acute illnesses (e.g., diabetic ketoacidosis)
Drugs:
Antimalarials (e.g., primaquine, pamaquine, chloroquine, Fansidar, Maloprim, quinine)
Sulphonamides and sulphones (e.g., co-trimoxazole, sulfanilamide, dapsone, sulfasalazine)
Other antibacterial agents (e.g., quinolones, nitrofurans, nalidixic acid, chloramphenicol)
Analgesics (e.g., aspirin); moderate doses are safe
Antihelminths (e.g., β-naphthol, stibophen)
Miscellaneous (e.g., vitamin K analogues, rasburicase, glibenclamide, naphthalene (mothballs), probenecid)
Fava beans
Chemical oxidants
N.B. Many common drugs have been reported to precipitate hemolysis in G6PD deficiency in some patients (e.g., aspirin, quinine, and penicillin), but not at conventional dosage.